41 – 50 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
LAMP2A as a therapeutic target in Parkinson disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2012
-
Mark
A Pilot Study Examining Associations between DYRK1A and alpha-Synuclein Dementias
(
- Contribution to journal › Article
-
Mark
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
(
- Contribution to journal › Article
-
Mark
Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates
(
- Contribution to journal › Article
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article
- 2011
-
Mark
Heredity in Parkinson's disease. From rare mutations to common genetic risk factors.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
GDNF fails to exert neuroprotection in a rat {alpha}-synuclein model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article